- Home
- VIRC vs NRXP Comparison
VIRC vs NRXP Comparison
Compare VIRC & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VIRC | NRXP |
|---|---|---|
| Founded | 1950 | 2015 |
| Country | United States | United States |
| Employees | N/A | 29 |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 99.1M | 99.2M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | VIRC | NRXP |
|---|---|---|
| Price | $6.17 | $4.17 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $7.30 | ★ $38.25 |
| AVG Volume (30 Days) | 118.4K | ★ 888.3K |
| Earning Date | 04-08-2026 | 05-14-2026 |
| Dividend Yield | ★ 1.65% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $199,652,000.00 | N/A |
| Revenue This Year | N/A | $2,547.84 |
| Revenue Next Year | $19.77 | $1,591.73 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.16 | $1.65 |
| 52 Week High | $9.07 | $5.06 |
Technical Indicators
Market Signals| Indicator | VIRC | NRXP |
|---|---|---|
| Relative Strength Index (RSI) | 49.82 | 55.88 |
| Support Level | $5.99 | $1.83 |
| Resistance Level | $6.50 | $4.20 |
| Average True Range (ATR) | 0.30 | 0.31 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 26.26 | 85.28 |
Price Performance
Historical ComparisonAbout VIRC Virco Manufacturing Corporation
Virco Manufacturing Corp is engaged in designing, production and distributing quality furniture for the commercial and education markets. The company manufactures an assortment of products, including mobile tables, mobile storage equipment, desks, computer furniture, chairs, activity tables, folding chairs, and folding tables. Its primary furniture lines are constructed of tubular metal legs and frames, combined with wood and plastic tops, plastic seats and backs, upholstered seats and backs, and upholstered rigid polyethylene and polypropylene shells.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.